Apricus Biosciences Inc news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

APRI 0.334 -0.006 (-1.62%)
price chart
Apricus Biosciences, Inc (APRI) Broker Price Targets For The Coming Week
11/06/2015 - Apricus Biosciences, Inc was downgraded to “neutral” by analysts at Roth Capital. They now have a USD 1.5 price target on the stock.
Apricus Biosciences Incorporated (NASDAQ:APRI) Sellers Increased By 2.33 ...  Press Telegraph
The Impact Score of Apricus Biosciences, Inc (NASDAQ:APRI) Is 90
As such, based on its algorithm-based analytics, Alpha One has given Apricus Biosciences, Inc (NASDAQ:APRI) daily sentiment score of -0.098.
Apricus Biosciences Inc (APRI): Price Target and June Short Interest Disclosure
Apricus Biosciences Inc (APRI) : Currently there are 3 street experts covering Apricus Biosciences Inc (APRI) stock.
Apricus Biosciences, Inc (NASDAQ:APRI) Upgrade Ratio At 0  Markets Daily
Apricus Biosciences Inc.
Apricus Biosciences Inc. NASDAQ: APRI. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
Apricus Biosciences Inc. ($APRI) Stock | Phase II Data Fails To Meet ...
Before the market opened this morning, Apicus Biosciences announced that their sexual dysfunction drug, Fispemifene, failed to reach statistical significance after completing its Phase II clinical trial.
Apricus Biosciences (APRI) Says Fispemifene Phase 2b Missed Primary ...  StreetInsider.com
Apricus Biosciences (APRI) Stock: Here's Why It's Tanking Today  CNA Finance (press release)
Stock Displaying Signs of a Downtrend: Apricus Biosciences, Inc. (NASDAQ:APRI)
Shares of Apricus Biosciences, Inc. (NASDAQ:APRI) have been on a consistent downtrend as of late, causing concern for stock owners.
Are Analysts Bearish Apricus Biosciences Inc (NASDAQ:APRI) After Last Week?
Out of 5 analysts covering Apricus Bioscience Inc (NASDAQ:APRI), 2 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 40% are positive.
Apricus Biosciences, Inc (NASDAQ:APRI)'s Basic Consolidated EPS Came In ...  Equities Focus
Apricus Biosciences, Inc (APRI) Analyst Price Targets For The Coming Week
11/06/2015 - Apricus Biosciences, Inc was downgraded to “neutral” by analysts at Roth Capital. They now have a USD 1.5 price target on the stock.
Apricus Biosciences, Inc (NASDAQ:APRI) Moderate Sell Ratings At 0
Apricus Biosciences, Inc (NASDAQ:APRI) strong sell score is 0 while buy rating count is 2. Moderate sell ratings are 0 while moderate buy calls are 0. Hold ratings count is 1. As many as 1 brokerages initiated coverage on Apricus Biosciences, Inc ...
Stock to Watch For Earnings: Apricus Biosciences, Inc. (APRI)
Apricus Biosciences, Inc. (APRI) is expected to report Q1 earnings estimated on Monday 05/09/2016. The company operates in the Drug Manufacturers - Other industry.